News
ELAB
2.560
+8.94%
0.210
Press Release: Elevai Labs Inc. Announces Name Change to PMGC Holdings Inc. and Redomicile to Nevada
Dow Jones · 1d ago
Elevai Labs plans name change to PMGC Holdings, redomicile to Nevada
TipRanks · 1d ago
Press Release: Elevai Labs Inc. Announces Anticipated Name Change to PMGC Holdings Inc. and Redomicile to Nevada
Dow Jones · 1d ago
Why Sangamo Therapeutics Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 3d ago
Weekly Report: what happened at ELAB last week (1209-1213)?
Weekly Report · 5d ago
Elevai Labs subsidiary announces FDA regulatory pathway for EL-22
TipRanks · 12/09 14:36
ELEVAI BIOSCIENCES, A SUBSIDIARY OF ELEVAI LABS INC., ANNOUNCES FDA REGULATORY PATHWAY FOR EL-22, A PIONEERING OBESITY THERAPY TARGETING FAT LOSS AND MUSCLE PRESERVATION
Reuters · 12/09 13:00
ELEVAI LABS - TO FILE IND APPLICATION WITH FDA IN 2025
Reuters · 12/09 13:00
Weekly Report: what happened at ELAB last week (1202-1206)?
Weekly Report · 12/09 12:38
Elevai Skincare Launches Innovative S-Series Root Renewal System for Hair and Scalp Health
Barchart · 12/06 16:50
Elevai Skincare launches S-Series Root Renewal System
TipRanks · 12/06 12:44
Elevai Labs Inc. Subsidiary, Elevai Skincare, Launches S-Series Root Renewal System, Marking Entry into Hair Care Market
Barchart · 12/06 06:30
Elevai Labs subsidiary achieved record-breaking month in sales for 2024
TipRanks · 12/04 13:11
Weekly Report: what happened at ELAB last week (1125-1129)?
Weekly Report · 12/02 12:38
ELEVAI Labs Inc trading halted, news pending
TipRanks · 11/27 00:55
BUZZ-U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals
Reuters · 11/25 14:20
Weekly Report: what happened at ELAB last week (1118-1122)?
Weekly Report · 11/25 12:25
BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, GE Vernova, EQT Corp
Reuters · 11/25 12:20
BUZZ-Elevai Labs falls after announcing 1-for-200 stock split
Reuters · 11/25 10:43
Why Uxin Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Benzinga · 11/25 10:27
More
Webull provides a variety of real-time ELAB stock news. You can receive the latest news about Elevai Labs, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ELAB
Elevai Labs, Inc. is a physician-dispensed skincare company. The Company conducts research and development to advance science-driven topical skincare that complements the medical aesthetics industry. It produces and commercializes topical skincare products that contain its proprietary stem cell derived Elevai Exosomes designed to enhance the appearance of skin. Its Precision Regenerative Exosome Technology (PREx) biotechnology process yields exosome lots from human umbilical cord-derived mesenchymal stem cells (hUMSC) for its specialty physician-dispensed skincare product lines. It has integrated the use of stem cell exosomes into its initial product line: Elevai Post Treatment E-Series. The E-Series comprises two post-skincare procedure care products that target the face and neck, and upper chest regions. Its products include Empower and Enfinity serums. Empower is its after-treatment topical product that supports the appearance of healthy skin and promotes an even toned complexion.